CAS: 80-74-0; N-((4-Aminophenyl)Sulfonyl)-N-(3,4-Dimethylisoxazol-5-yl)Acetamide

该化合物是一种化学化合物,属于硫化物衍生物类别,该物质具有硫化物特性,因其抗菌特性而闻名,以及一种异氧氮酸盐环,有助于其独特的化学行为;异氧烷环上存在的二甲基组加强其脂性,有可能影响其生物活动和溶解性;该化合物的特点是其晶状固体形式,在标准条件下可能表现出中度稳定;其应用可能包括药物用途,特别是在抗微生物剂的开发中;与许多氟化物衍生物一样,它也可能与生物系统相互作用,需要仔细考虑其药用和毒性;

结构式图片

上下游产品

sulfisoxazole acetic anhydrideN-(3,4-dimethyl-isoxazol-5-yl)-N-(4-xanthen-9-ylamino-benzenesulfonyl)-acetamideN-(3,4-dimethyl-isoxazol-5-yl)-N-(4-xanthen-9-ylamino-benzenesulfonyl)-acetamide

合成工艺路线路线简述

  • 127-69-5 = 80-74-0
    反应条件:1.1 Solvents: Water; Rt1.2 Reagents: Sodium Hydroxide Solvents: Water; 15 Min,Ph 8 - 9,40 - 50 °C; Overnight,0 °C2.1 Solvents: Acetone; 30 Min,35 - 40 °C; 5 - 6 H,Rt2.2 Reagents: Ammonia Solvents: Water; 30 Min,0 - 10 °C
    标题:Process For Preparation Of Sulfisoxazole Acetyl
    参考文献:China]

    2200-44-4 = 80-74-0
    反应条件:1.1 Solvents: Acetone; 30 Min,35 - 40 °C; 5 - 6 H,Rt1.2 Reagents: Ammonia Solvents: Water; 30 Min,0 - 10 °C
    标题:Process For Preparation Of Sulfisoxazole Acetyl
    参考文献:China
磺胺异噁唑,乙酸酐 反应生成 乙酰磺胺异噁唑
参考文献:Kano Et Al.,Shionogi Kenkyusho Nenpo,1955,# 5,P. 32,35
标题:Kano Et Al.,Shionogi Kenkyusho Nenpo,1955,# 5,P. 32,35

海关参考信息

专利信息


专利号:US-8557979-B2
优先权日:2004-06-10
标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
发明人:CHOI WOO-BAEG; KOWALIK EWA
权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

专利号:US-2008300418-A1
优先权日:2004-11-08
标 题:Synthesis of Cardiolipin Analogues and Uses Thereof
发明人:AHMAD MOGHIS U; UKKALAM MURALI K; ALI SHOUKATH M; AHMAD IMRAN
权利人:AHMAD MOGHIS U; UKKALAM MURALI K; ALI SHOUKATH M; AHMAD IMRAN
摘要:The invention provides novel synthetic methodologies for preparing cardiolipin, migrated caridiolipin (1,2-positional isomer of cardiolipin) and their analogues having varying fatty acids and/or alkyl chains with varying length and degrees of saturation/unsaturation. The method comprises (a) reacting an optically pure 1,2-O-dialkyl-sn-glycerol or 1,2-O-dialkyl-sn-glycerol with one or more phosphoramidite reagent(s), wherein a phosphite triester is produced; (b) coupling the product of (a) with glycerol, wherein a protected cardiolipin is produced; and (c) deprotecting the protected cardiolipin, such that cardiolipin is prepared. The cardiolipins and analogues thereof, prepared by the present methods, can be incorporated into liposomes, which can also include active agents such as hydrophobic or hydrophilic drugs, antisense nucleotides or diagnostic agents. Such liposomes can be used to treat diseases or can be used in diagnostic and/or analytical assays.

专利号:US-10933051-B2
优先权日:2017-06-09
标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections
发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN
权利人:FOB SYNTHESIS INC
摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

专利号:US-9693999-B2
优先权日:2011-01-26
标题:Small molecule RNase inhibitors and methods of use
发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

专利号:US-2006078560-A1
优先权日:2003-06-23
标 题 :Method of inducing apoptosis and inhibiting cardiolipin synthesis
发明人:JAMIL HARIS; AHMAD MOGHIS U; AHMAD IMRAN
权利人:NEOPHARM INC
摘要:The present invention provides a method for inducing apoptosis within a cell by exposing the cell to an inhibitor of cardiolipin synthesis under conditions sufficient to induce apoptosis within the cell. The method can be used to investigate or treat disorders such as cancer, obesity, and cardiovascular disorders. The invention also provides a pharmaceutical composition including an inhibitor of cardiolipin synthesis and a liposomal carrier.

专利号:US-2008286351-A1
优先权日:2004-06-29
标 题:Pegylated Cardiolipin Analogs, Methods of Synthesis, and Uses Thereof
发明人:AHMAD MOGHIS U; UKKALAM MURALI K; ALI SHOUKATH M; AHMAD IMRAN
权利人:AHMAD MOGHIS U; UKKALAM MURALI K; ALI SHOUKATH M; AHMAD IMRAN
摘要:The invention provides synthetic methods for PEGylated cardiolipins with varying linkers. The methods can be employed to prepare PEGylated cardiolipin with different fatty acid and/or alkyl chain length with or without unsaturation. The PEGylated cardiolipin, prepared by the present methods, can be incorporated into liposomes that can also include active agents such as hydrophilic or hydrophobic drugs for the treatment of human and animal diseases. In addition, the PEGylated cardiolipin can be incorporated into liposomes that include compounds for therapeutic and diagnostic imaging. The use of such liposomes with PEGylated cardiolipin prolongs the period of liposomal circulation without disrupting the lipid bilayer.
上海东满进出口有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.domen.com.cn
企业联系电话:021-61066956/57/58,61043548👤
📞上海东满进出口有限公司 ⚠️参考联系方式
联系人:董连锁
电话:021-61066956/57/58,61043548

传真:021-61043546
邮箱:sales@domen.com.cn
通信地址: 上海市浦东新区新金桥路1088号中惠广场A座1907室
邮编: 201206
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:上海市浦东新区新金桥路1088号中惠广场A座1907室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
浙江海昇药业股份有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: https://www.zcpc.net/
企业联系电话:0570-8750611;8750616;8750618;8750620;8750500-8055👤
📞浙江海昇药业股份有限公司 ⚠️参考联系方式
联系人:张琳;崔霞霞;陈一晟;周逸君
电话:0570-8750611;8750616;8750618;8750620;8750500-8055
手机:13357006799;15317109187;18868105702;18805706626
传真:0570-8750617
邮箱:zhl@zcpc.net;cxx@zcpc.net;eason@zcpc.net;Steve@zcpc.net
通信地址: 浙江省衢州市高新技术产业园区华阳路36号
邮编: 324000
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江省衢州市高新技术产业园区华阳路36号
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献


1: Kim E, Kang W. Simultaneous determination of N(1)-acetyl sulfisoxazole and its metabolites, and relative bioavailability compare to sulfisoxazole in rats. J Pharm Biomed Anal. 2016 Sep 10;129:117-120. doi: 10.1016/j.jpba.2016.06.055. Epub 2016 Jul 1. doi: 10.1016/j.jpba.2016.07.029. Epub 2016 Jul 18.
7: Oie S, Gambertoglio JG, Fleckenstein L. Comparison of the disposition of total and unbound sulfisoxazole after single and multiple dosing. J Pharmacokinet Biopharm. 1982 Apr;10(2):157-72. French. Review. French.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知